MERSANA THERAPEUTICS INC. - COMMON STOCK
0.5854
18-فبراير-25 12:59:31
15 متأخرة بدقائق
الأسهم
+0.0034
+0.58%
نطاق اليوم
0.5682 - 0.6200
ISIN
N/A
المصدر
NASDAQ
-
Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023
31 أكتوبر 2023 15:30:25 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056
31 أكتوبر 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Changes in Leadership
06 سبتمبر 2023 06:00:40 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
08 أغسطس 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 أغسطس 2023 15:05:52 بحسب Nasdaq GlobeNewswire
-
27 يوليو 2023 06:06:23 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 يوليو 2023 15:05:00 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
15 يونيو 2023 06:30:00 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 يونيو 2023 15:05:00 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
24 مايو 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
09 مايو 2023 06:00:01 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 مايو 2023 15:05:01 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Bank of America Securities 2023 Healthcare Conference
03 مايو 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host First Quarter 2023 Conference Call on May 9, 2023
02 مايو 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Upcoming Presentations at 2023 ASCO Annual Meeting
26 أبريل 2023 15:05:01 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 أبريل 2023 15:05:00 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial
13 مارس 2023 06:30:00 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Statement About SVB
10 مارس 2023 18:10:38 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 مارس 2023 15:05:00 بحسب Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Fourth Quarter and Year End 2022 Conference Call on February 28, 2023
21 فبراير 2023 07:00:01 بحسب Nasdaq GlobeNewswire